Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MARKSANS PHARMA.   ADCOCK INGRAM
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
ADCOCK INGRAM
Jun-14
MARKSANS PHARMA./
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs74321-   
Low Rs39232-   
Sales per share (Unadj.) Rs40.995.5-  
Earnings per share (Unadj.) Rs5.9-24.1-  
Cash flow per share (Unadj.) Rs7.0-20.0-  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.575.0-  
Shares outstanding (eoy) m453.16168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.42.9 47.8%   
Avg P/E ratio x9.7-11.5 -84.1%  
P/CF ratio (eoy) x8.1-13.9 -58.3%  
Price / Book Value ratio x1.53.7 39.8%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,63146,656 54.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,3942,928 81.7%   
Avg. sales/employee Rs Th03,756.2-  
Avg. wages/employee Rs Th0682.1-  
Avg. net profit/employee Rs Th0-946.5-  
INCOME DATA
Net Sales Rs m18,52116,125 114.9%  
Other income Rs m593113 525.3%   
Total revenues Rs m19,11516,238 117.7%   
Gross profit Rs m3,393-2,794 -121.4%  
Depreciation Rs m519696 74.5%   
Interest Rs m91437 20.9%   
Profit before tax Rs m3,377-3,814 -88.5%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723238 303.5%   
Profit after tax Rs m2,653-4,063 -65.3%  
Gross profit margin %18.3-17.3 -105.7%  
Effective tax rate %21.4-6.2 -342.8%   
Net profit margin %14.3-25.2 -56.9%  
BALANCE SHEET DATA
Current assets Rs m16,99711,810 143.9%   
Current liabilities Rs m3,6546,645 55.0%   
Net working cap to sales %72.032.0 224.9%  
Current ratio x4.71.8 261.7%  
Inventory Days Days6111 5.1%  
Debtors Days Days82124 66.3%  
Net fixed assets Rs m5,2466,884 76.2%   
Share capital Rs m45375 605.3%   
"Free" reserves Rs m16,9980-   
Net worth Rs m17,45212,657 137.9%   
Long term debt Rs m04,448 0.0%   
Total assets Rs m22,24223,909 93.0%  
Interest coverage x38.0-7.7 -491.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 123.5%   
Return on assets %12.3-15.2 -81.4%  
Return on equity %15.2-32.1 -47.4%  
Return on capital %19.9-19.8 -100.3%  
Exports to sales %00-   
Imports to sales %7.30-   
Net fx Rs m5,1430-   
CASH FLOW
From Operations Rs m2,3741,376 172.5%  
From Investments Rs m-2,592-423 613.3%  
From Financial Activity Rs m1,9784,037 49.0%  
Net Cashflow Rs m1,7604,990 35.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.43 Rs / ZAR

Compare MARKSANS PHARMA. With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare MARKSANS PHARMA. With: AUROBINDO PHARMA  VIMTA LABS  SAROJA PHARMA INDUSTRIES INDIA LTD.  ADVIK LABORS  CIPLA  



Today's Market

Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising Sensex Today Rallies 941 Points | Bank Nifty Hits Record High | 5 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.